| Effect of a pharmacist-managed culture review process on antimicrobial therapy in an emergency department. | |
| | |
MedLine Citation:
|
PMID: 21546643 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Purpose The impact of an emergency department (ED) procedure requiring pharmacist review of all culture results as a way to improve use of antimicrobial therapies was evaluated. Methods Rates of antimicrobial regimen modifications before and after implementation of a pharmacist-managed ED culture review procedure at Carolinas Medical Center-Northeast were determined through retrospective evaluation of medical records. To assess the potential impact of pharmacist-initiated antimicrobial regimen modifications on overall patient care, the frequency of ED readmissions within 96 hours of ED discharge and the reasons for those readmissions were evaluated. Results In the 12 months before implementation of the pharmacist-managed ED culture review process, the medical center's ED physicians reviewed 2278 culture reports and ordered antimicrobial regimen modifications in about 12% of cases; in about 19% of cases, patients were readmitted to the ED within 96 hours of discharge for treatment failure, patient noncompliance, allergy to medication, adverse drug reactions, and other reasons. In the 12 months after program implementation, pharmacists initiated antimicrobial regimen modifications in about 15% of cases; readmission to the ED occurred in about 7% of cases, with comparatively lower rates of readmission for treatment failure, noncompliance, and allergy to medication. Conclusion ED pharmacists at Carolinas Medical Center-Northeast designed and implemented a pharmacist-managed culture review process. During a one-year period, ED pharmacists reviewed 2361 culture reports and modified the antimicrobial regimens of 355 patients. |
| | |
Authors:
|
Timothy C Randolph; Andrea Parker; Liz Meyer; Renee Zeina |
Related Documents
:
|
21480493 - Evaluation of a hospital-based tobacco treatment service: outcomes and lessons learned. 6230893 - The research and development of a 5-ht selective reuptake blocker. preclinical aspects. 11007093 - Treatment of nasal polyposis in byzantine times. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists Volume: 68 ISSN: 1535-2900 ISO Abbreviation: Am J Health Syst Pharm Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-05-06 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9503023 Medline TA: Am J Health Syst Pharm Country: United States |
Other Details:
|
Languages: eng Pagination: 916-9 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Efficacy of limited cefuroxime prophylaxis in pediatric patients after cardiovascular surgery.
Next Document: Projecting future drug expenditures--2011.